Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ANIS TOUMEH

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1780999326
CMS profile
1370996
Location
GARDEN CITY, KS

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$6,151.22

115 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $3,855.00 2
Food and Beverage $2,227.26 109
Education $68.96 4

By paying entity

PY2022 · entire year · sorted by reported total

Page 3 of 3; records 101–115 of 115 matching records. This page contains 15 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ANIS TOUMEH

NPI 1780999326 · CMS profile ID 1370996

Allopathic & Osteopathic Physicians / Internal Medicine / Medical Oncology

GARDEN CITY, KS

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–115 of 115 matching records. This page contains 15 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1780999326?year=2022&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ANIS TOUMEH, NPI 1780999326, CMS profile ID 1370996. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–115 of 115 matching records. This page contains 15 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1780999326?year=2022&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). ANIS TOUMEH, NPI 1780999326, CMS profile ID 1370996. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–115 of 115 matching records. This page contains 15 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1780999326?year=2022&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
ANIS TOUMEH, NPI 1780999326, CMS profile ID 1370996, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–115 of 115 matching records. This page contains 15 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1780999326?year=2022&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

115 matching records · $6,151.22 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 115 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–115 of 115.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Exelixis Inc. $22.9102/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932460921 CMS
Seagen Inc. $16.7802/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 904124079 CMS
Incyte Corporation $15.6402/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943039373 CMS
EISAI INC. $11.1402/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908017727 CMS
Kyowa Kirin, Inc. $14.9802/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 905038457 CMS
Takeda Pharmaceuticals U.S.A., Inc. $20.3602/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 955855663 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $14.6102/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887392433 CMS
Kite Pharma, Inc. $17.4101/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920060725 CMS
Coherus Biosciences Inc. $13.4701/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 956563063 CMS
Janssen Biotech, Inc. $25.5101/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885908117 CMS
BeiGene USA, Inc. $15.2801/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940796899 CMS
EISAI INC. $11.4401/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908017763 CMS
Astellas Pharma US Inc $16.2201/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940097397 CMS
Regeneron Healthcare Solutions, Inc. $38.0201/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 927448689 CMS
ABBVIE INC. $17.1401/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892543071 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,272.56 77
PY2020 $268.92 18
PY2021 $2,001.70 48
PY2022 $6,151.22 115
PY2023 $9,193.93 18
PY2024 $8,929.94 48
PY2025 $11,885.06 43

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $239,808.95 10
PY2024 Principal investigator $29,799.38 4
PY2021 Principal investigator $2,540.00 2
PY2020 Principal investigator $1,405.00 6
PY2019 Principal investigator $380.00 7

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

10 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Genentech, Inc. $3,158.00 12/23/2025 Non-covered Recipient Entity
HCA RESEARCH INSTITUTE LLC
Giredestrant CDKi of Choice in ESR1m Enriched 1L HR mBC Secondary Endocrine Resistant Patients No dispute reported 06/30/2026 1211612087
Principal investigator 1 Genentech, Inc. $13,800.00 12/09/2025 Non-covered Recipient Entity
HCA RESEARCH INSTITUTE LLC
INAVO123 No dispute reported 06/30/2026 1211612017
Principal investigator 1 Genentech, Inc. $22,072.00 09/03/2025 Non-covered Recipient Entity
HCA RESEARCH INSTITUTE LLC
Giredestrant CDKi of Choice in ESR1m Enriched 1L HR mBC Secondary Endocrine Resistant Patients No dispute reported 06/30/2026 1211612077
Principal investigator 1 Genentech, Inc. $3,479.00 09/02/2025 Non-covered Recipient Entity
HCA RESEARCH INSTITUTE LLC
Giredestrant CDKi of Choice in ESR1m Enriched 1L HR mBC Secondary Endocrine Resistant Patients No dispute reported 06/30/2026 1211612083
Principal investigator 1 Novartis Pharmaceuticals Corporation $108,654.11 06/30/2025 Non-covered Recipient Entity
HCA MIDWEST DIVISION
A Phase IIIb Study to Characterize the Effectiveness and Safety of Adjuvant Ribociclib in a Wide Patient Population With HR+ HER2- Early Breast Cancer (Adjuvant WIDER) No dispute reported 06/30/2026 1190309060
Principal investigator 1 Eli Lilly and Company $156.05 05/08/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE LLC
A PHASE 3 OPEN-LABEL, RANDOMIZED STUDY OF FIXED DURATION PIRTOBRUTINIB (LOXO-305) PLUS VENETOCLAX AND RITUXIMAB VERSUS VENETOCLAX AND RITUXIMAB IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (BRUIN CLL-322) No dispute reported 06/30/2026 1187887476
Principal investigator 1 Genentech, Inc. $29,039.00 05/08/2025 Non-covered Recipient Entity
HCA RESEARCH INSTITUTE LLC
Giredestrant CDKi of Choice in ESR1m Enriched 1L HR mBC Secondary Endocrine Resistant Patients No dispute reported 06/30/2026 1211612048
Principal investigator 1 Eli Lilly and Company $11,458.09 02/19/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE LLC
A PHASE 3 OPEN-LABEL, RANDOMIZED STUDY OF FIXED DURATION PIRTOBRUTINIB (LOXO-305) PLUS VENETOCLAX AND RITUXIMAB VERSUS VENETOCLAX AND RITUXIMAB IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (BRUIN CLL-322) No dispute reported 06/30/2026 1187888080
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $5,592.00 01/27/2025 Non-covered Recipient Entity
Midwest Oncology Associates - Kansas City
A Phase 3, Two-stage, Randomized, Multi-center, Controlled, Open-label Study Comparing Iberdomide Maintenance to Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation (ASCT) in Participants with Newly Diagnosed Multiple Myeloma (NDMM) (Excaliber-Maintenance) No dispute reported 06/30/2026 1235995689
Principal investigator 2 Celgene Corporation $42,400.70 01/08/2025 Non-covered Recipient Entity
Hca Midamerica Division
A Phase 3, Two-stage, Randomized, Multi-center, Controlled, Open-label Study Comparing Iberdomide Maintenance to Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation (ASCT) in Participants with Newly Diagnosed Multiple Myeloma (NDMM) (Excaliber-Maintenance) No dispute reported 06/30/2026 1222305380